Idexx Laboratories IDXX Allowance for Doubtful Accounts Receivable (Current)
Allowance for Doubtful Accounts Receivable (Current) at other companies
Other financials
Where this comes from
Reported directly by Idexx Laboratories in its filing.
Tagged under the XBRL concept us-gaap:AllowanceForDoubtfulAccountsReceivable.
The source filing: Idexx Laboratories’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:14 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0000874716-26-000076
The allowance for credit losses associated with accounts receivable was $14.3 million and $11.3 million as of March 31, 2026, and December 31, 2025, respectively. The amount of accounts receivable reflected on the balance sheet is net of this allowance. As of March 31, 2026, approximately 88% of our accounts receivable had not yet reached the invoice due date and approximately 12% were considered past due. As of December 31, 2025, approximately 87% of our accounts receivable had not yet reached the invoice due date and approximately 13% were considered past due.
Item 1. Financial Statements (unaudited)
FAQ
- What is Idexx Laboratories's allowance for doubtful accounts receivable (current)?
- Idexx Laboratories (IDXX) reported allowance for doubtful accounts receivable (current) of $14.3M in Q1 2026.
- How has Idexx Laboratories's allowance for doubtful accounts receivable (current) changed year-over-year?
- Idexx Laboratories's allowance for doubtful accounts receivable (current) increased by 12.6% year-over-year, from $12.7M to $14.3M.
- What is the long-term trend for Idexx Laboratories's allowance for doubtful accounts receivable (current)?
- Over 5 years (2020 to 2025), Idexx Laboratories's allowance for doubtful accounts receivable (current) has grown at a 10.7% compound annual growth rate (CAGR), from $6.8M to $11.3M.
- What does allowance for doubtful accounts receivable (current) mean?
- This is the valuation allowance for current receivables that are considered uncollectible due to disputes, bankruptcy, or other non-payment issues. It serves as a buffer against potential losses from customer defaults. It is a critical indicator of the health of the company's accounts receivable portfolio.
Ask your AI about Idexx Laboratories's allowance for doubtful accounts receivable (current).
Connect your AI assistant and compare it to peers, right in your chat.
